Roche, Entero Healthcare join hands for key nephrology drugs

"While we keep working towards creating and enhancing the healthcare ecosystem in India, we need to differentiate between our existing products that can reach the patients at a faster pace through a valued partnership like this, and the newer innovative drugs that we can focus on bringing into India in next few years." said V. Simpson Emmanuel, General Manager, Roche Products (India) Pvt. Ltd."At Roche Pharma India, we are focusing on strategic approaches to ensure robust access, better healthcare financing and overall enhanced healthcare ecosystem. A partnership in India for our Nephrology portfolio is one such important step in ensuring that we bring world-class medicines and healthcare solutions to our country through an esteemed partner like Entero Healthcare Solutions. We remain committed to transforming healthcare in India to become a benchmark for other emerging markets around the globe."

Prabhat Agrawal, Co-founder and CEO, Entero Healthcare Solutions Pvt. Ltd. said, "We are delighted to enter this unique collaboration with Roche to be able to serve patient needs in the area of organ transplant and chronic kidney disease. There has been a significant rise in the number of patients with kidney-related ailments and with Entero's presence across major cities in India, we aspire to make these innovative set of medicines accessible to every patient."

Read also: Roche, Cipla collaborate for key oncology drugs